Perrigo Company plc (BVMF:P1RG34)

Market Cap	12.10B +8.6%
Revenue (ttm)	21.27B -4.5%
Net Income	-9.20B
EPS	-70.06
Shares Out	n/a
PE Ratio	n/a
Forward PE	6.83
Dividend	4.26 (4.99%)
Ex-Dividend Date	Nov 26, 2026

Volume	3
Open	83.04
Previous Close	n/a
Day's Range	83.04 - 85.41
52-Week Range	49.00 - 85.41
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2026

About Perrigo Company

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pai...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1887
• Employees: 8,100
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: P1RG34

Financial Performance

In 2025, Perrigo Company's revenue was $4.25 billion, a decrease of -2.75% compared to the previous year's $4.37 billion. Losses were -$1.43 billion, 729.7% more than in 2024.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 9, 2026

Data Sources Report a data error